Table 1 (abstract A87). Demographic and clinical history data between groups
From: Abstracts of the ICARE 2024 78th SIAARTI National Congress
N = 60 | QLBIII (N = 20) | ESP (N = 20) | Control (N = 20) |  |  | ||||
N | (%) | N | (%) | N | (%) | χ2 | p-value | ||
CS indications | Previous CS | 16 | 80.0% | 17 | 85.0% | 15 | 75.0% | 0.63 | 0.732 |
Maternal request | 4 | 20.0% | 3 | 15.0% | 5 | 25.0% | 0.63 | 0.732 | |
Comorbidities | Total | 11 | 55.0% | 12 | 60.0% | 11 | 55.0% | 0.14 | 0.935 |
Pregnancy Cholestasis | 1 | 5.0% | 1 | 5.0% | 1 | 5.0% | 0.00 | 1 | |
Gestational diabetes | 3 | 15.0% | 2 | 10.0% | 1 | 5.0% | 1.11 | 0.574 | |
Dysthyroidism | 6 | 30.0% | 8 | 40.0% | 7 | 35.0% | 0.44 | 0.803 | |
Gestational hypertension | 0 | 0.0% | 1 | 5.0% | 1 | 5.0% | 0.00 | 1 | |
Previous DVT | 1 | 5.0% | 0 | 0.0% | 1 | 5.0% | 0 | 1 | |
| Â | Mean | SD | Mean | SD | Mean | SD | ANOVA | p-value | |
Gestational age | Week | 38 | 1 | 38 | 1 | 38 | 1 | 0.00 | 1 |
BMI | kg/m2 | 26.2 | 2.6 | 27.0 | 2.6 | 25.3 | 2.4 | 2.25 | 0.115 |